Unclaimed brand
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#0061A0
Endeavour
0, 97, 160
204, 100, 31
100, 39, 0, 37
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
Osteal Therapeutics is a privately held, clinical-stage pharmaceutical company focused on developing treatments for orthopedic infections and their consequences. The company aims to improve care for patients with musculoskeletal infections, whose outcomes can be poor and unpredictable, by creating targeted therapies that help orthopedic surgeons address infection more rapidly and reliably. Its mission is to improve patient outcomes, quality of life, and the cost of care, with a broader vision of reducing the burden of orthopedic infection for patients, clinicians, and healthcare systems.
Osteal’s clinical programs are informed by the needs of patients and orthopedic surgeons. The company conducts clinical trials and offers an expanded-access program, and its portfolio includes the NEXCHANGE Kit. Osteal has reported positive six- and twelve-month results from its APEX clinical trial program, with findings presented at meetings of the Musculoskeletal Infection Society and the American Association of Hip and Knee Surgeons in 2024. Through its work in musculoskeletal therapeutics, Osteal seeks to provide new tools for treating orthopedic infection and helping patients return to their lives.
